Donna R. Cryer, JD is Founder, President and Chief Executive Officer of the Global Liver Institute (GLI), the only patient-driven liver health nonprofit operating in the US and Europe. She has channeled her personal experience as a patient with inflammatory bowel disease and a 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. GLI established and leads the 70-member NASH Council, created the Beyond the Biopsy Campaign to advance non-invasive technologies in the liver field, and represents the patient community in the FNIH NIMBLE Consortium and the Liver Forum. Mrs. Cryer serves on the Boards of Directors of The Innovation and Value Initiative (IVI), the Sibley Memorial Hospital/Johns Hopkins Medicine, the Executive Committee for the Clinical Trials Transformation Initiative and the Executive Advisory Committee for Tivity Health (NASDAQ: TVTY). Mrs. Cryer received an undergraduate degree from Harvard/Radcliffe Colleges and a Juris Doctorate from the Georgetown University Law Center.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.